pharma · Cerebral adrenoleukodystrophy (cALD) · Adrenoleukodystrophy
Minoryx Therapeutics
Minoryx Therapeutics S.L.
Minoryx Therapeutics patent portfolio — 0 USPTO pharmaceutical patents (A61K/A61P) with grant dates, status, and loss-of-exclusivity filters.
Company details
- Status
- Public
- HQ
- ES
- Founded
- 2011
- Employees
- 32
- Programs
- 4
- Drugs
- 11
- Patents
- 0
Minoryx Therapeutics patents
0 pharmaceutical patents indexed for Minoryx Therapeutics. 0 expire within 24 months.
Minoryx Therapeutics has 0 pharmaceutical patents in our USPTO PatentsView index (A61K/A61P). 0 expire within 24 months — use filters for patent-cliff planning.
No patents matched
Frequently asked questions
How many patents does Minoryx Therapeutics have?
0 published patents match the current filter (all indexed). The full portfolio is indexed from USPTO PatentsView (A61K/A61P).
When do Minoryx Therapeutics patents expire?
0 patents in the full portfolio expire within 24 months. Use the expiring filters above or open individual patent pages for grant and expiration dates.